【摘 要】
：
Over the past decade,traditional Chinese medicine (TCM) has widely embraced systems biology and its various data integration approaches to promote its modernization.Thus,integrative pharmacology-based traditional Chinese medicine (TCMIP) was proposed as a
【机 构】
：
Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;S
论文部分内容阅读
Over the past decade,traditional Chinese medicine (TCM) has widely embraced systems biology and its various data integration approaches to promote its modernization.Thus,integrative pharmacology-based traditional Chinese medicine (TCMIP) was proposed as a paradigm shift in TCM.This review focuses on the presentation of this novel concept and the main research contents,meth-odologies and applications of TCMIP.First,TCMIP is an interdisciplinary science that can establish qual-itative and quantitative pharmacokinetics-pharmacodynamics (PK-PD) correlations through the integration of knowledge from multiple disciplines and techniques and from different PK-PD processes in vivo.Then,the main research contents of TCMIP are introduced as follows:chemical and ADME/PK profiles of TCM formulas;confirming the three forms of active substances and the three action modes;establishing the qualitative PK-PD correlation;and building the quantitative PK-PD correlations,etc.After that,we summarize the existing data resources,computational models and experimental methods of TCMIP and highlight the urgent establishment of mathematical modeling and experimental methods.Finally,we further discuss the applications of TCMIP for the improvement of TCM quality control,clar-ification of the molecular mechanisms underlying the actions of TCMs and discovery of potential new drugs,especially TCM-related combination drug discovery.
其他文献
In vitro-in vivo correlation(IVIVC)of solid dosage forms should be established basically between in vitro and in vivo dissolution of active pharmaceutical ingredients.Nevertheless,in vivo disso-lution profiles have never been accurately portrayed.The curr
Psoriasis is an autoimmune inflammatory disease,where dendritic cells(DCs)play an impor-tant role in its pathogenesis.In our previous work,we have demonstrated that topical delivery of curcumin-loaded poly(lactic-co-glycolic acid)(PLGA)nanoparticles(NPs)c
New approaches to cancer immunotherapy have been developed,showing the ability to harness the immune system to treat and eliminate cancer.For many solid tumors,therapy with checkpoint inhibitors has shown promise.For hematologic malignancies,adoptive and
The management of the central nervous system(CNS)disorders is challenging,due to the need of drugs to cross the blood-brain barrier(BBB)and reach the brain.Among the various strategies that have been studied to circumvent this challenge,the use of the int
This special APSB issue marks the beginning of a series of celebratory events for the 10-year anniversary of the journal.It was June 2011,when the first issue of the journal was published.It has been an exciting decade for the growth of the journal,which
Liver is the most common metastatic site for colorectal cancer(CRC),there is no satisfied approach to treat CRC liver metastasis(CRCLM).Here,we investigated the role of a polycomb protein BMI-1 in CRCLM.Immunohistochemical analysis showed that BMI-1 expre
Anoctamin 1 (ANO1) or TMEM16A gene encodes a member of Ca2+ activated C1-channels(CaCCs) that are critical for physiological functions,such as epithelial secretion,smooth muscle contrac-tion and sensory signal transduction.The attraction and interest in A
Nature has endowed gaseous molecules such as O2,CO2,CO,NO,H2S,and N2 with critical and diverse roles in sustaining life,from supplying energy needed to power life and building blocks for life\'s physical structure to mediating and coordinating cellular
The recent discovery of activator compounds binding to an allosteric site on the NAD+-dependent protein lysine deacetylase,sirtuin 6(SIRT6)has attracted interest and presents a pharmaceu-tical target for aging-related and cancer diseases.However,the mecha
HYD-PEP06,an endostatin-modified polypeptide,has been shown to produce effective anti-colorectal carcinoma effects through inhibiting epithelial--mesenchymal transition (EMT).However,whether HYD-PEP06 has similar suppressive effect on hepatocellular carci